Coronavirus (COVID-19) Treatment

The coronavirus (COVID-19) pandemic is unprecedented and is placing huge demands on the whole healthcare system. The situation is ongoing and rapidly changing.

The Clinical Policies and Decisions team have created this section of the website to host links to national websites for coronavirus related information.

Points to note:

  • GP's are not expected to prescribe or supply nMABs or antivirals
  • Majority of patients identified centrally and will be contacted by the CMDU
  • The pathway describes the national policy which has been locally adapted
COVID-19 Community Based Treatments Content Summary

NHSE/I COVID-19 Community Based Treatments

Information of Community based treatments including policy, contact details of COVID Medicine Delivery Unit Directory and information for patients

Derbyshire Neutralising Monoclonal Antibodies (nMABs) or antivirals for non-hospitalised patients with COVID-19 pathway


Information on the local Derbyshire pathway for patients who are identified as follows:

  • via NHS Digital
  • via contact with primary care (in and out of hours)

COVID-19 Medicine Delivery Unit (CMDU)

There are a modest number of patients who will not be identified automatically.

Referral can be made to the local CMDU service via the Electronic Referral Service, or via the direct number used for Red Hub referrals 0300 1000 432 or by emailing UCD.admin@nhs.net.

Please include:

  • Patient details
  • NHS number
  • Underlying qualifying clinical condition
  • Date of symptom onset
  • Date of PCR
  • Where possible, also include a copy of the PCR pathology report

Out of Area information can be found here 

 

National Guidance Content summary
GOV.UK COVID-19: guidance for health professionals

Information on COVID-19, including guidance on the assessment and management of suspected UK cases

NHSE/I Coronavirus guidance for clinicians and NHS managers

Overview of all NHSE/I guidelines for primary care, secondary care and community based health, social care, mental health trusts and ambulance services

NICE specialty guides

These guides are aimed at specialists working in hospitals in England during the pandemic. They aim to help departments continue essential care for patients while supporting the wider hospital and community to provide care for people with COVID-19.

SPS specialty guidance

Overview of all SPS specialty guidance for medicine optimisation
Other Useful Links Content summary

British Geriatric Society

This resource series brings together current advice from experts within the BGS relating to older people and the current COVID-19 pandemic

British Society for Rheumatology

Overview of all BSR's resources on rheumatology and COVID-19

British Thoracic Society

During the pandemic, BTS worked with a range of partners to produce guidance and collate information relating to COVID-19 including management of existing conditions, shielding and the resumption of services.

Please note that the individual guidance documents, some of which may have been more relevant during the peaks of the pandemic, are not being reviewed or updated.  This should be considered when referring to the information provided.

DCHS Care Home COVID Support Service

A multidisciplinary team consisting of registered staff including Nursing, Physiotherapy, Occupational Therapy, Speech and Language Therapy, Pharmacy, Podiatry and Continence services will provide a virtual service for non-urgent needs to support the care home provider in the ongoing care of residents during the pandemic

Derby & Derbyshire Clinical Commissioning Group COVID-19 intranet page updates for GP practices

DDCCG intranet page for COVID-19 updates for practices

Derbyshire Alliance for End of Life Care

The Derbyshire Alliance offers education for professionals working across our county and allows colleagues to demonstrate their continuing professional development.

Interim Clinical Commissioning Policy: IL-6 inhibitors (tocilizumab or sarilumab) for hospitalised patients with COVID-19 (adults)

The proposal is: IL-6 inhibitors tocilizumab and sarilumab are recommended to be available as treatment options through routine commissioning for adult patients (aged 18 years and older) hospitalised with COVID-19 in accordance with the criteria set out in this document

Kidney Care UK - Coronavirus (COVID-19)

The latest news and information about COVID-19 for kidney patients

National Pharmacy Association

Pharmacy resources, guidance and support for the Coronavirus COVID-19 pandemic

Pharmaceutical Services Negotiating Committee

PSNC’s COVID-19 hub contains links to information, guidance and resources on the COVID-19 (coronavirus) pandemic for community pharmacy contractors and their teams.

PrescQIPP COVID-19

This page has been set up for CCGs and Health Boards to share the resources that they have developed locally to support their local areas with COVID 19 issues.

Primary Care Pharmacy Network

This PCPA COVID-19 Hub has been set up as a central point for peer to peer sharing of resources and information. Access is free to all pharmacy professionals.

These resources have been shared on this group and are updated as they are received.

Public Health England - GOV.UK

Guidance and support on the Coronavirus COVID-19 pandemic

The British Voice Association

Advice for people experiencing voice problems after COVID-19

Your COVID recovery

The new 'Your COVID recovery' service forms part of the NHS plans to expand access to COVID-19 rehabilitation treatments for those who have survived the virus but still have problems with breathing, mental health problems or other complications.

This guidance is aimed at clinicians who are consulting remotely with patients through a digital channel (e.g. online, email, text, video-link) across healthcare settings in England.

The principals described in the guidance aim to support patients to access care in a way that meets their needs and to support clinicians to provide care in a way that is in the best interest of their patients, whilst protecting both from the risks associated with remote intimate assessments.